key: cord-0279863-1bkl2nk6
authors: TIMUR, D.; DEMIRPEK, U.; ERTEK, E.; AYDIN, O. C.; KARABIYIK, T.; KAYADIBI, H.
title: COMPARISON OF SARS-COV-2 WUHAN AND ALPHA VARIANTS: CLINICAL AND LABORATORY HIGHLIGHTS
date: 2022-05-19
journal: nan
DOI: 10.1101/2022.05.17.22275188
sha: d43693629bd70193d55489fb9a260b9ba46ac314
doc_id: 279863
cord_uid: 1bkl2nk6

Since December 2019, after the declaration of new cases regarding novel coronavirus disease, many variants have emerged as a consequence of the viral evolution. Though the SARS-CoV-2 variants have been studied for molecular basis, the clinical and pathologic disparities of them have been understood inadequately. The aim of this research was to figure out the differences between the SARS-CoV-2 Alpha (B1.1.7) variant and the classical Wuhan groups on the clinical basis and laboratory results of the COVID-19 patients who had positive PCR test. The study was done retrospectively inclusive of epidemiological, laboratory data and clinical symptoms of patients who were admitted to the emergency service between February 15 and March 15, 2021 and had positive COVID-19 PCR test results. Though there was no statistically significant difference in symptoms between SARS-CoV-2 Alpha variant and classical variant (Wuhan type) groups; C-reactive protein (CRP), lymphocyte and leukocyte counts were statistically significantly higher in the Wuhan type group; prothrombin time (PT), International Normalized Ratio (INR) and serum creatinine values were statistically significantly higher in the Alpha group. Studies such as ours that investigate both the clinical features and laboratory data of SARS-CoV-2 variants will close the knowledge gaps, so better decisions may be made by health policy makers. Additional studies in this area will increase the understanding of the topic.

The globe had burst into Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) disease in [3, 4] . Understanding of new genetic variants may contribute to better diagnostics, also to the comprehension of both unpredictable increase in contagiousness and the disease severity. Moreover, it has been hypothesized that weak antibodies resulting from previous infection or vaccination may cause treatment unresponsiveness [3, 5] . Alpha variant (B.1.1.7) was first detected in the UK in September 2020 and spread to many countries [6, 7] . After the Alpha variant was also seen in Turkey, it quickly became the dominant strain [8] .

Although routine laboratory tests are not specific to the disease, their contribution to the evaluation of severity and progress is pivotal. Because it is imperative to understand concomitant complications and the situation of the organs involved. Based on this, the epidemiological and laboratory data of Alpha and Wuhan type SARS-CoV2 variants were investigated within the scope of the COVID-19 pandemic in our hospital.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

This study included the patient population (n = 379) who visited the emergency service for the suspicion of 

R-based Jamovi (Sydney, Australia) 1.6.23 was used for statistical analysis. Shapiro-Wilk test was used to determine the conformity of variables to a normal distribution. Student's t-test was used to compare normally distributed parameters between the groups, and Mann-Whitney U test was used to compare non-normal . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2022. ; https://doi.org/10.1101/2022.05.17.22275188 doi: medRxiv preprint distributed parameters between groups. Chi-square test was performed to investigate whether there was a difference between categorical variables.

The study included 379 patients who had come to the emergency department between February 15 and International normalized ratio (INR) (P= 0.011) and creatinine (P= 0.042) were found to be statistically significantly higher in the alpha group. When the symptoms were compared between the groups, no statistically significant differences were found for any of the symptoms.

In this study, when patients with COVID-19 infection were evaluated in terms of mortality, eight patients out of 189 patients with alpha variant and six patients out of 190 patients with Wuhan type had died. There were no statistically significant differences between alpha variant and Wuhan type for the death rates. On behalf of the symptoms encountered in those patients, no significant differences were found between the two groups of this study.

As the new SARS-CoV-2 variants emerge due to the mutations, new variants affect the clinical picture and laboratory data. In our study, we compared the clinical and laboratory data of patients with SARS-CoV-2 alpha variant and Wuhan type.

Symptoms such as fever, cough, weakness, shortness of breath, loss of taste and smell, which are frequently encountered in SARS-CoV-2 infection, are non-specific symptoms. In a study of Bhatraju et al., conducted at ICU, the most common symptoms of COVID-19 patients were cough, shortness of breath, and fever, as well as were observed in 50% of these patients' at the time of admissions to the hospital [9] . In a study conducted with 1099 patient data in China, when the duration of hospital stay is included, the most common symptom is fever, while the second symptom is cough [10] . Sahin et al., figured out that fever and cough were the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2022. ; https://doi.org/10.1101/2022.05.17.22275188 doi: medRxiv preprint most common symptoms [11] . In our study, the most common symptoms were cough, malaise and fever. In another study, Alp et al., found that the clinical presentations of both confirmed and probable cases could vary in a wide spectrum [12] . We concluded that the abundance of clinical spectra could be linked to the presence of different variants (VOC).

In a survey of patients infected with the alpha variant; cough, fatigue, sore throat, myalgia, and a history of fever within 7 days prior to the test were more common, while loss of taste and smell (anosmia and ageusia) were found less [13] . Graham et al., on the other hand, showed that there is no direct relationship between symptoms and alpha variant, as we found [14] . Tsai et al., studied the analysis of deaths occurring in the alpha variant infected 636 patients, the mortality rate of symptomatic patients was low; however, elder patients with no symptoms had higher mortality rate [15] . In our study, no statistically significant differences was found when we compared groups in terms of mortality and symptoms.

In different studies, statistically significantly higher rates of hospitalization, admission to intensive care units, and death were found in the alpha variant compared to the classical variant [16, 17] . Graham et al., indicated that also our research noticed, the rates of asymptomatic cases and hospital admissions were not altered by alpha variant [14] .

In COVID-19 infection, lymphopenia, leukocytosis, hypoalbuminemia, neutrophilia, thrombocytopenia and increased troponin, creatinine, AST, ALT, CRP, PT, aPTT, D-dimer levels were observed [18, 19] . In our study, PT and creatinine values were found to be statistically higher in the alpha variant group.

In a study conducted by Guan et al. with the data of 1099 patients, 83% lymphocytopenia, 36% thrombocytopenia and 34% leukopenia were found at the time of admission. While CRP elevation was the most common result; ALT, AST, CK, and D-dimer level elevations were observed less frequently [10] . In favor of inauguration to predict disease progression in COVID-19 at early disease stages, e.g. at hospital admission, the value of biomarkers is imperative. The results have the potential to be used to improve the management of COVID-19 patients for identification of high-risk groups and pertinent handling of healthcare resources in the pandemic. Ozkarafakılı et al., found that there was no association between the human blood groups and laboratory results. In our study, human blood groups were not evaluated [20] .

While the WBC counts were higher in severe COVID-19 infections, the lymphocyte counts were statistically significantly lower. A high neutrophil/lymphocyte ratio indicates critical illness and poor prognosis [21, 22] .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2022 In addition to the increase in the N/L ratio (NLR), many studies also indicate increases in CRP and D-dimer levels, supporting the severity of the COVID-19 infection [23, 24] . In our study, CRP levels were higher in the Wuhan type group. When the two groups were compared in terms of symptoms, no statistically significant differences were found. In a study conducted by Song et al.; CRP, CK, D-dimer levels were found to be statistically significantly higher in the alpha variant patients' group while there were no statistically significant differences between the two groups in terms of WBC, neutrophil, platelet, lymphocyte, ALT and AST values [25] . Dagcioglu et al., found that the lymphocytes counts were higher in the alpha variant patients' group; whereas WBC count, neutrophil count, NLR and ferritin values were found to be lower [26] .

In another study with 158 patients, Vassallo et al. found the platelet count to be higher in the alpha variant patient group, while the CRP, D-dimer and NLR were not statistically significantly different between the two groups. The alpha variant was found to have a four-fold higher risk of death and hospitalization in intensive care [27] . In our study, CRP levels, lymphocyte and leukocyte counts were found to be statistically significantly higher in the Wuhan type patient group. These results showed statistically significant differences between the alpha variant and the Wuhan type variant groups.

In this study, no differences were found in terms of symptoms in both variant groups. When laboratory data were examined; CRP levels, lymphocyte and leukocyte counts were found to be statistically significantly higher in the Wuhan type group. PT and creatinine were found to be statistically significantly higher in the alpha variant group. In our study, however, no statistically significant difference was found between the variant groups in terms of mortality and all evaluated symptoms. As mentioned in this study, the increase in . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2022. ; https://doi.org/10.1101/2022.05.17.22275188 doi: medRxiv preprint

Emergence of a new SARS-CoV-2 variant in the UK

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

New variant of SARS-CoV-2 in UK causes surge of COVID-19

Alpha variant (B.1.1.7) of SARS-CoV-2 increases fatality-rate for patients under age of 70 years and hospitalization risk overall

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Clinical Characteristics of Coronavirus Disease 2019 in China

Pediatric Patients with COVID-19: A Retrospective Single-Center Experience

Evaluation of Patients with Suspicion of COVID-19 in Pediatric Emergency Department. Sisli Etfal Hastan Tip Bul

Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario

The laboratory's role in combating COVID-19

COVID-19 and the clinical hematology laboratory

Relationship between ABO blood types and COVID-19 severity

A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients

Clinical laboratory evaluation of COVID-19

Clinical and laboratory features of COVID-19: Predictors of severe prognosis

Biomarkers associated with COVID-19 disease progression

CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The copyright holder for this preprint this version posted May 19, 2022 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2022. ; https://doi.org/10.1101/2022.05.17.22275188 doi: medRxiv preprint